VanEck Pharmaceutical ETF
PPH
PPH
44 hedge funds and large institutions have $122M invested in VanEck Pharmaceutical ETF in 2018 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 19 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
68% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 19
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $1.04M
Holders
44
Holding in Top 10
–
Calls
–
Puts
$1.04M
Top Buyers
| 1 | +$360K | |
| 2 | +$131K | |
| 3 | +$61.3K | |
| 4 |
APP
Avantax Planning Partners
Dubuque,
Iowa
|
+$48K |
| 5 |
LPL Financial
San Diego,
California
|
+$40.4K |
Top Sellers
| 1 | -$8.67M | |
| 2 | -$2.05M | |
| 3 | -$2.02M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$1.67M |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1.5M |